Sign In
test

Mark Doherty

Superstring Capital Management Lp

Assets Managed
$139.97M
Holdings
35
Last Quarter
2026 - Q1
Filed Date
21d ago
Growth Rate
-25.06%(2Q avg: 29.48%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Superstring Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 35 positions.

Assets under management

The assets under management (AUM) of Superstring Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 139.97M in assets, with a quarterly growth rate of -25.06% and a 2-quarter average growth rate of 29.48%. The portfolio is managed by Mark Doherty, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
SMMT
Summit Therapeutics Inc
Recent Activity
New Position
12.1%
$16.929M
892,873 shares@ $18.96 avg price
IMVT
Immunovant Inc
Recent Activity
Increased 23.88%
6.35%
$8.883M
357,606 shares@ $24.84 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Decreased -38.52%
6.2%
$8.666M
225,158 shares@ $38.49 avg price
SVRA
Savara Inc
Recent Activity
Increased 59.34%
6.19%
$8.659M
1.586M shares@ $5.46 avg price
URGN
Urogen Pharma Ltd
Recent Activity
Decreased -46.07%
4.98%
$6.965M
387,371 shares@ $17.99 avg price
DFTX
Definium Therapeutics Inc
Recent Activity
New Position
4.75%
$6.643M
351,461 shares@ $18.91 avg price
VIR
Vir Biotechnology Inc
Recent Activity
New Position
4.68%
$6.546M
730,548 shares@ $8.96 avg price
PCVX
Vaxcyte Inc
Recent Activity
New Position
4.59%
$6.418M
110,454 shares@ $58.12 avg price
CLDX
Celldex Therapeutics Inc
Recent Activity
Increased 103.89%
4.09%
$5.711M
180,048 shares@ $31.73 avg price
SION
Sionna Therapeutics Inc
Recent Activity
Decreased -21.91%
4.04%
$5.654M
141,024 shares@ $40.09 avg price

1-10 of 35